RT Journal Article SR Electronic T1 Cardiorespiratory Fitness and Neuromuscular Performance in Patients Recovered from COVID-19 JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.11.20248930 DO 10.1101/2021.01.11.20248930 A1 Murillo Frazão A1 Amilton da Cruz Santos A1 Lucas de Assis Pereira Cacau A1 Paulo Eugênio Silva A1 Tullio Rocha Petrucci A1 Mariela Cometki Assis A1 Rômulo de Almeida Leal A1 Cláudia Lúcia de Moraes Forjaz A1 Maria do Socorro Brasileiro-Santos YR 2021 UL http://medrxiv.org/content/early/2021/01/13/2021.01.11.20248930.abstract AB Objective COVID-19 affects cardiorespiratory and muscular systems, causing dysfunctions that may persist after recovery from the acute infection and treatment. The aim of this study was to evaluate cardiorespiratory fitness and neuromuscular performance in these patients.Methods Patients recovered from mild (n=31) and severe (n=17) COVID-19 were evaluated and compared to healthy subjects (n=15). All volunteers underwent a maximal cardiopulmonary exercise test with simultaneous acquisition of electromyography (EMG). Power output, oxygen uptake (VO2), pulse oxygen (O2Pulse), cardiovascular efficiency (ΔHR/ΔVO2), ventilation (VE), breathing reserve (BR) and ventilatory efficiency (VE/VCO2 slope) were analyzed. From EMG, power output for type Ia and IIa activation as well as total neuromuscular efficiency (Δwatts/Δ%RMS) were determined.Results Patients with severe COVID-19 presented lower VO2, O2Pulse and VE than mild COVID-19 patients and healthy subjects (p < 0.05 for all comparisons). No differences in ΔHR/ΔVO2, BR or VE/VCO2 slope were observed among the groups (p > 0.05 for all comparisons). Type IIa and IIb fibers were activated at lower power output in severe than in mild COVID-19 patients and healthy subjects (p < 0.05). Δwatts/Δ%RMS was lower in severe than in mild COVID-19 patients and healthy subjects (p < 0.05).Conclusion Patients recovered from severe COVID-19 present low cardiorespiratory fitness, activate glycolytic fibers at low power outputs, and show low neuromuscular efficiency; while patients recovered from mild COVID-19 do not present these sequels.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialRBR-6xqcr4Funding StatementFederal University of Paraiba supported this work by paying the english review.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the local research ethics committee (Instituto de Educacao Superior da Paraiba - IESP, opinion No. 4.132.248, CAAE No. 34234720.0.0000.5184) and was registered in the Brazilian Clinical Trial Registration Platform (Number: RBR-6xqcr4)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe state that all data of this manuscript are available.